Thrombolex Inc.

Founded in 2016, Thrombolex, Inc. is engaged in the design, development, manufacture and distribution of innovative endovascular catheters.

04/07/2026

Thrombolex will be attending the Society of Interventional Radiology Annual Scientific Meeting. We look forward to connecting with the interventional radiology community and continuing conversations around targeted PE treatment and procedural approaches that support precision and clinical confidence in patient care.

Thrombolex.com

04/05/2026

Happy Easter from Thrombolex.

Thrombolex.com

03/31/2026

Thrombolex will be attending the Society of Interventional Radiology (SIR) Annual Scientific Meeting coming next month.

We look forward to connecting with the Interventional Radiology community and continuing discussions around targeted PE therapy and procedural approaches that support precision and clinical confidence in patient care.

Thrombolex.com

03/19/2026

Thrombolex has closed a $50M Series A financing led by OrbiMed, with continued support from existing investors.

This milestone strengthens our ability to support clinicians treating pulmonary embolism and artrerial/venous thrombus with approaches that combine mechanical clot engagement and targeted thrombolytic delivery.

The investment will support:

→ Expanded commercial reach to more hospitals and care teams
→ Continued clinical programs, including further evidence generation
→ Organizational growth to support long-term scale

President and CEO Mike Cerminaro highlights the company’s appreciation for its clinical partners, whose insights and feedback continue to guide advances in endovascular treatment.

Learn more in the full announcement: https://thrombolex.com/thrombolex-secures-50m-series-a-financing-to-advance-endovascular-treatment-for-pulmonary-embolism-and-venous-thrombus/

03/08/2026

The BASHIR™ Plus Endovascular Device is designed for targeted thrombolytic delivery in peripheral vessels. The expandable infusion basket and variable distal-shaft infusion lengths provide procedural flexibility and controlled delivery to support safe and efficient treatment of venous thrombus.

Thrombolex.com

03/04/2026

Combining mechanical fragmentation and targeted lytic delivery, the BASHIR™ Plus Endovascular Device elevates treatment of venous thrombus while giving clinicians clinical confidence.

Thrombolex.com

03/01/2026

The BASHIR™ Endovascular Device is designed for precise pharmaco-mechanical lysis (PML) through on-the-table treatment. It delivers targeted thrombolytic therapy along with mechanical clot fragmentation, which helps restore blood flow safely and efficiently in the treatment of pulmonary embolism (PE).

Thrombolex.com

02/28/2026

Today at PEGASUS Endovascular, Vivian Bishay, MD will present a case of submassive pulmonary embolism (PE) treated with pharmaco-mechanical intervention using the BASHIR™ Endovascular Catheter.

The session begins today, Saturday, February 28 at 11:36 AM and will share real-world insights into procedural approach and targeted therapy in PE management. We hope you can join the meeting.

https://m3meet.com/pegasusendovascular-2026

Thrombolex.com

02/27/2026

Thrombolex will be at AVF 2026. As venous care evolves, we remain focused on delivering precise, targeted approaches that support procedural control and clinical confidence. We look forward to continuing the discussion with you at the conference.

Thrombolex.com

02/25/2026

Join Thrombolex at PEGASUS Endovascular for a virtual clinical case presentation on submassive pulmonary embolism (PE) treated with Pharmaco-Mechanical intervention using the BASHIR™ Endovascular Catheter.

Vivian Bishay, MD of Mount Sinai Hospital, NY will present this case, highlighting procedural considerations and the role of mechanical fragmentation and targeted thrombolysis in PE treatment.

https://m3meet.com/pegasusendovascular-2026

Thrombolex.com

02/24/2026

Thrombolex will be attending AVF 2026, booth #11. We look forward to engaging with the venous community and continuing conversations around targeted, thrombolytic therapy and procedural approaches that support safe, efficient treatment for venous disease.

Thrombolex.com

02/22/2026

The BASHIR™ Endovascular Device is designed for efficient placement, controlled mechanical fragmentation and targeted delivery of thrombolytics for the treatment of pulmonary embolism. Its 0.035"" guidewire compatibility supports procedural ease and speed while enabling on-the-table pharmaco-mechanical lysis (PML).

Thrombolex.com

Address

75 Britain Drive
New Britain, PA
18901

Telephone

+18447926300

Website

http://www.thrombolex.com/

Alerts

Be the first to know and let us send you an email when Thrombolex Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Thrombolex Inc.:

Shortcuts

Want your practice to be the top-listed Clinic in New Britain?